Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 8, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 7, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 25, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 17, 2016View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-136

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information